X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
abridged index medicus (1) 1
aged (1) 1
amylin (1) 1
cardiovascular disease (1) 1
cardiovascular diseases - complications (1) 1
cardiovascular diseases - epidemiology (1) 1
cardiovascular diseases - mortality (1) 1
cardiovascular diseases - prevention & control (1) 1
cerebral infarction (1) 1
clinical medicine (1) 1
diabetes (1) 1
diabetes mellitus (1) 1
diabetes mellitus, type 2 - blood (1) 1
diabetes mellitus, type 2 - complications (1) 1
diabetes mellitus, type 2 - drug therapy (1) 1
dosage and administration (1) 1
double-blind method (1) 1
drug administration schedule (1) 1
drug therapy (1) 1
endocrinology (1) 1
event lowering exscel (1) 1
exenatide (1) 1
female (1) 1
glucose control (1) 1
health risk assessment (1) 1
heart diseases (1) 1
humans (1) 1
hypoglycemic agents - administration & dosage (1) 1
hypoglycemic agents - adverse effects (1) 1
incidence (1) 1
index medicus (1) 1
injections, subcutaneous (1) 1
kaplan-meier estimate (1) 1
klinisk medicin (1) 1
least-squares analysis (1) 1
male (1) 1
medical and health sciences (1) 1
medicin och hälsovetenskap (1) 1
medicine (1) 1
medicine, general & internal (1) 1
middle aged (1) 1
myocardial infarction (1) 1
observations (1) 1
outcome and process assessment (1) 1
pancreatic cancer (1) 1
pancreatic carcinoma (1) 1
pancreatitis (1) 1
patient outcomes (1) 1
patients (1) 1
peptides - administration & dosage (1) 1
peptides - adverse effects (1) 1
pharmaceuticals (1) 1
reports (1) 1
risk (1) 1
side effects (1) 1
studies (1) 1
thyroid carcinoma (1) 1
type 2 diabetes (1) 1
type 2 diabetes, glp1-agonists, exenatide, cardiovascular effects (1) 1
usage (1) 1
venoms - administration & dosage (1) 1
venoms - adverse effects (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 09/2017, Volume 377, Issue 13, pp. 1228 - 1239
This trial, which compared once-weekly exenatide plus usual care with usual care alone in patients with type 2 diabetes with or without previous cardiovascular... 
Medicine(all) | MEDICINE, GENERAL & INTERNAL | RISK | EVENT LOWERING EXSCEL | GLUCOSE CONTROL | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Male | Exenatide | Peptides - administration & dosage | Incidence | Cardiovascular Diseases - complications | Hypoglycemic Agents - administration & dosage | Injections, Subcutaneous | Cardiovascular Diseases - epidemiology | Cardiovascular Diseases - mortality | Venoms - administration & dosage | Female | Diabetes Mellitus, Type 2 - complications | Double-Blind Method | Drug Administration Schedule | Venoms - adverse effects | Kaplan-Meier Estimate | Diabetes Mellitus, Type 2 - blood | Least-Squares Analysis | Aged | Diabetes Mellitus, Type 2 - drug therapy | Hypoglycemic Agents - adverse effects | Peptides - adverse effects | Type 2 diabetes | Usage | Patient outcomes | Outcome and process assessment (Health Care) | Reports | Dosage and administration | Drug therapy | Observations | Myocardial infarction | Cerebral infarction | Diabetes mellitus | Pancreatitis | Amylin | Cardiovascular disease | Patients | Thyroid carcinoma | Studies | Side effects | Pancreatic carcinoma | Pancreatic cancer | Diabetes | Health risk assessment | Heart diseases | Endocrinology | Pharmaceuticals | Clinical Medicine | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.